Cargando…

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort

BACKGROUND: Identifying individuals at risk of developing Parkinson's disease (PD) is critical to define target populations for future neuroprotective trials. OBJECTIVE: The objective of this study was to apply the PREDICT‐PD algorithm of risk indicators for PD in a prospective community‐based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marini, Kathrin, Mahlknecht, Philipp, Tutzer, Franziska, Stockner, Heike, Gasperi, Arno, Djamshidian, Atbin, Willeit, Peter, Kiechl, Stefan, Willeit, Johann, Rungger, Gregorio, Noyce, Alastair J., Schrag, Anette, Poewe, Werner, Seppi, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540037/ https://www.ncbi.nlm.nih.gov/pubmed/32491231 http://dx.doi.org/10.1002/mds.28127

Ejemplares similares

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60–97 Years: A Population-Based Study
por: Mahlknecht, Philipp, et al.
Publicado: (2013)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
por: Mahlknecht, Philipp, et al.
Publicado: (2016)

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye‐Tracking Study
por: Carbone, Federico, et al.
Publicado: (2021)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Prodromal Parkinson's disease: hype or hope for disease-modification trials?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants
por: Tschiderer, Lena, et al.
Publicado: (2017)

The prodromes of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease
por: Djamshidian, Atbin, et al.
Publicado: (2015)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Ultrasound-detected inflammation is more common in clinically manifest hand osteoarthritis than in painless bony enlarged finger joints: subanalysis of the population-based Bruneck study
por: Gasperi, Nina, et al.
Publicado: (2022)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Osteoprotegerin and Cardiovascular Events in High‐Risk Populations: Meta‐Analysis of 19 Prospective Studies Involving 27 450 Participants
por: Tschiderer, Lena, et al.
Publicado: (2018)

Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies
por: Knoflach, Michael, et al.
Publicado: (2012)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease
por: Peball, Marina, et al.
Publicado: (2023)

Long-term life history predicts current gut microbiome in a population-based cohort study
por: Si, Jiyeon, et al.
Publicado: (2022)

Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
por: Paige, Ellie, et al.
Publicado: (2017)

Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation
por: Heim, Beatrice, et al.
Publicado: (2017)

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
por: Heim, Beatrice, et al.
Publicado: (2022)

Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
por: Mahlknecht, Philipp, et al.
Publicado: (2020)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Haptoglobin 2‐2 Genotype is Not Associated With Cardiovascular Risk in Subjects With Elevated Glycohemoglobin—Results From the Bruneck Study
por: Pechlaner, Raimund, et al.
Publicado: (2014)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Reflection impulsivity perceptual decision‐making in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2018)

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
por: Poewe, Werner, et al.
Publicado: (2021)

Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack –study protocol
por: Toell, Thomas, et al.
Publicado: (2018)

Recanalization of Extracranial Internal Carotid Artery Occlusion after i.v. Thrombolysis for Acute Ischemic Stroke
por: Pechlaner, Raimund, et al.
Publicado: (2013)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: A randomised clinical trial
por: Willeit, Peter, et al.
Publicado: (2020)

High-Normal HbA(1c) Is a Strong Predictor of Type 2 Diabetes in the General Population
por: Bonora, Enzo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_08pp35savd8dov6g3882ssspn5